960151-85-3

Upstream product

• 106-45-6 para-thiocresol 
• 15861-49-1 1-bromo-2-(4-methylphenylsulfanyl)benzene 
• 583-53-9 2,3-dibromobenzene 

Downstream Products

• 1093111-60-4 4-(2-(4-tolylsulfanyl)phenyl)piperidin monomaleate 
• 1093111-57-9 4-(2-(4-tolylsulfanyl)phenyl)piperidin monosuccinate 
• 960151-74-0 4-(2-(4-tolylsulfanyl)phenyl)piperidin palmitate 
• 960151-82-0 Tedatioxetine D-tartrate 
• 960151-75-1 4-(2-(4-tolylsulfanyl)phenyl)piperidin monoadipate 
• 960151-81-9 4-(2-(4-tolylsulfanyl)phenyl)piperidin monomalate 
• 960151-69-3 4-(2-(4-tolylsulfanyl)phenyl)piperidin mono-L-aspartate 
• 960151-67-1 4-(2-(4-tolylsulfanyl)phenyl)piperidin monoglutarate 
• 960151-77-3 Tedatioxetine fumarate 
• 960151-68-2 Tedatioxetine malonate 
• 960151-78-4 Tedatioxetine oxalate 
• 960151-84-2 Tedatioxetine phosphate 
• 960151-66-0 Tedatioxetine lactate 
• 1058738-31-0 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine hydrochloride 

Relevant academic research and scientific papers

Therapeutic Uses Of Compounds Having Affinity To The Serotonin Transporter, Serotonin Receptors And Noradrenalin Transporter

Therapeutic uses of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine and therapeutically acceptable salts thereof are provide.

PROCESS FOR THE MANUFACTURE OF [PHENYLSULFANYLPHENYL]PIPERIDINES

A process for the manufacture of (un)substituted phenylsulfanylphenyl-piperidines comprising the use of benzyl as N-piperidine protecting group is disclosed.

NOVEL THERAPEUTIC USES OF 4-[2-(4-METHYLPHENYLSULFANYL)PHENYL]PIPERIDINE

The use of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine and acid additions salts thereof for the treatment of ADHD, melancholia, treatment resistant depression or residual symptoms in depression is provided.